DRD3 and Dyskinesia: In another study, the carriers of dopamine receptor DRD2 and DRD3 haplotypes, as well as the BDNF variant rs6265, were associated with an increased risk of dyskinesia, suggesting that these genes may be implicated in dyskinesia-related pathomechanisms in Parkinson’s disease patients [89].